Scientist III, Analytical Development and Clinical QC

BioCT Innovation Commons

New Haven, Northern (CT, KY)

Hybrid

USD 120,000 - 180,000

Full time

14 days+
Application generator

An application made for this job — a tailored resume and cover letter that speak straight to the posting.

Get past ATS filters

Job summary

Alexion in New Haven, CT, seeks an experienced Scientist II in Analytical Development and Clinical QC to lead late-stage analytical strategies through Phase 3 and commercialization. Expect method transfer, validation, and regulatory filings, with cross-functional collaboration across PDCS, Regulatory, QA, and external labs.

The role requires 4+ years in biologics analytical development and strong expertise in chromatography, CE-SDS, cIEF, bioassays, and impurity testing.

Qualifications

  • Advanced degree (PhD or MSc) in Biochemistry, Analytical Chemistry, Molecular Biology, Pharmaceutical Sciences, or related field
  • 4+ years of progressive experience in biologics analytical development across clinical and commercial stages
  • Proven hands-on strategic and technical expertise with monoclonal antibodies, bispecific, fusion proteins
  • Technical expertise in chromatography (SEC, RP, IEX), capillary electrophoresis (CE-SDS, cIEF), spectroscopy (UV/Vis, fluorescence, CD), bioassays (binding, potency), and residuals/impurities testing (HCP, DNA, residual Protein A)
  • Compendia method experience with a focus on USP, EP and JP compliance
  • Strong written and verbal skills for reports, regulatory submissions, and presentations
  • Demonstrated success in method development, qualification/validation (ICH Q2), transfer to QC/CMOs, and continued verification for commercial control strategies
  • GxP documentation, ALCOA+ data integrity, OOS/OOT handling, deviation/CAPA management, and audit readiness
  • Ability to define CQAs and implement commercial control strategies aligned with QbD

Responsibilities

  • Lead all aspects of analytical method validations, transfers, and compendia verifications across clinical development and life-cycle stages
  • Serve as analytical lead for CMC programs, focusing on late-stage programs with cross-functional collaboration
  • Develop and implement end-to-end analytical strategy for key late-stage biologics programs, including control strategy and QC oversight
  • Lead analytical QC testing, troubleshooting, and data analysis to ensure program health and identify risks
  • Author regulatory submissions for clinical and commercial markets and respond to agency queries

Skills

Analytical development
Biologics expertise
Monoclonal antibodies
QC/CMO transfer
CTD/regulatory submissions

Education

PhD or MSc in Biochemistry/Analytical Chemistry

Tools

LIMS
ELN
Chromatography Data Systems
JMP

Job description

As a Scientist II in Analytical Development and Clinical QC at Alexion, you'll be at the forefront of our Late-Stage Analytical team! This pivotal role demands analytical expertise and a proven track record in managing analytical development projects throughout the CMC lifecycle. You'll prioritize multiple projects, collaborating closely with PDCS teams, Regulatory, QA, and external QC laboratories. Develop and implement late-stage analytical strategies, including method transfer, validation, and verification, while authoring regulatory filings with a keen understanding of country-specific requirements. As the analytical functional lead for clinical CMC programs, you'll drive end-to-end analytical activities from Phase 3 through commercialization.

Accountabilities
  • Lead all aspects of analytical method validations, transfers, and compendia method verifications across all stages of clinical development and method life-cycle stages.
  • Serve as the analytical lead for CMC programs, focusing on late-stage programs with rigorous cross-functional collaboration.
  • Develop and implement an analytical end-to-end strategy for key late-stage biologics programs, including control strategy, lifecycle management, and QC testing oversight.
  • Lead all aspects of analytical QC testing, troubleshooting issues, and conduct data analysis to ensure program health and identify potential risks.
  • Author regulatory submissions for clinical and commercial markets, addressing health authority queries and requests for information.
Essential Skills/Experience
  • Advanced degree (PhD or MSc) in Biochemistry, Analytical Chemistry, Molecular Biology, Pharmaceutical Sciences, or related field
  • 4+ years of progressive experience in biologics analytical development across clinical and commercial stages.
  • Proven hands‑on strategic and technical expertise with monoclonal antibodies, bispecific, fusion proteins.
  • Technical expertise in chromatography (e.g., SEC, RP, IEX), capillary electrophoresis (CE‑SDS, cIEF), spectroscopy (UV/Vis, fluorescence, CD), bioassays (binding, potency), and residuals/impurities testing (HCP, DNA, residual Protein A)
  • Compendia method experience with a focus on USP, EP and JP compliance
  • Strong written and verbal skills for clear reports, regulatory submissions, and presentations to technical and non-technical collaborators
  • Demonstrated success in method development, qualification/validation (per ICH Q2), transfer to QC/CMOs, and continued verification for commercial control strategies.
  • Strong command of ICH (Q5E, Q6B, Q8–Q12), USP/EP, FDA/EMA expectations for biologics, GMP/GLP compliance, and authoring/reviewing CTD Module 3, IND/IMPD, BLA/MAA analytical sections and responses to agency queries.
  • Proficiency with GxP compliant documentation, ALCOA+ data integrity principles, OOS/OOT handling, deviation/CAPA management, and audit readiness
  • Ability to define critical quality attributes (CQAs build specifications, and implement commercial control strategies aligned with Quality by Design (QbD)
  • The duties of this role are generally conducted in a lab environment. As is typical of a lab-based role, employees must be able, with or without an accommodation to: lift/carry 15/30 pounds unassisted/assisted; work comfortably in a controlled environment with and around biological, infectious, and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours.
  • Agility / Adapatability (Changing direction as conditions shift) (reframing and pivoting, abandoning outdated approaches)
  • Learning Mindset (Learning, unlearning, and applying quickly) (Curiosity & feedback‑seeking, transfer of learning, self‑directed, growth mindset independent of role)
  • Agency (Taking ownership and driving action without waiting for instruction — making things happen) (Proactively identifying problems, acting without permission when needed, personal accountability for outcomes, persistence in overcoming obstacles)
Desirable Skills/Experience
  • Background in analytical method development and sound scientific understanding of Critical Quality Attributes/QbD/DOE principles as well as statistical data analysis and relevant tools
  • Leading all aspects of CDMO/CRO analytical activities including routine testing oversight, troubleshooting and investigations and method qualification, validation, and transfer.
  • Experience in country specific compendia requirements and knowledge of CHP
  • Experience in ICH stability programs (Q1), shelf-life modeling and projections and related statistical approaches
  • Experience in extended characterization and comparability including forced degradation studies for process comparability and life cycle management.
  • Digital laboratory systems and automation: Familiarity with LIMS, ELN, Chromatography Data Systems, data visualization, and automation/robotics in analytical workflows
  • Expertise with AI tools and statistical software, for example jmp

When we put unexpected teams in the same room, we fuel ambitious thinking with the power to encourage life‑changing medicines. In‑person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of four days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our outstanding and ambitious world.

At AstraZeneca's Alexion division, your work is more than just a job - it's a mission to transform lives. Our dedication to patients drives everything we do. With a rapidly growing portfolio and entrepreneurial spirit akin to a leading biotech company, you'll thrive in an environment that develops innovation and growth. Here you'll find an encouraging community of leaders and peers dedicated to making a difference for those living with rare diseases. Your career journey will be enriched by tailored development programs that align your growth with our mission.

Date Posted

10-Sep-2026

Closing Date

30-Sep-2026

Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Scientist III, Analytical Development and Clinical QC
Scientist III, Analytical Development and Clinical QC

AstraZeneca GmbH • New Haven (CT), Northern (KY)

Hybrid
USD 110,000 - 170,000
Office flexibility
Onsite collaboration
Associate Director, Analytical Development and Clinical QC
Associate Director, Analytical Development and Clinical QC

Alexion Pharmaceuticals, Inc. • New Haven (CT)

On-site
USD 100,000 - 150,000
Scientist III, Analytical Development and Clinical QC New Haven, Connecticut, United States of America LGY_SCPE - Pharmaceutical Science Posted a day ago
Scientist III, Analytical Development and Clinical QC New Haven, Connecticut, United States of America LGY_SCPE - Pharmaceutical Science Posted a day ago

Alexion Pharma Spain S.L. • New Haven (CT), Northern (KY)

Hybrid
USD 120,000 - 170,000
Associate Director, Analytical Development and Clinical QC
Associate Director, Analytical Development and Clinical QC

AstraZeneca • New Haven (CT)

On-site
USD 180,000 - 230,000
Director, Clinical Development Scientist
Director, Clinical Development Scientist

AstraZeneca • Boston (MA)

Hybrid
USD 204,000 - 306,000
Development Scientist III, Analytical Development and Clinical Quality Control
Development Scientist III, Analytical Development and Clinical Quality Control

BioCT Innovation Commons • New Haven (CT)

On-site
USD 138,000 - 208,000
Health benefits including medical, prescription drug, dental, and vision
401(k) retirement plan
Paid vacation and holidays
Medical Director Clinical Development Neurology
Medical Director Clinical Development Neurology

Alexion Pharmaceuticals, Inc. • Boston (MA)

Hybrid
USD 241,000 - 363,000
Health, dental, and vision coverage
Paid time off (vacation, holiday, and leaves)
Short-term incentive bonuses
Development Scientist III, Analytical Development and Clinical Quality Control
Development Scientist III, Analytical Development and Clinical Quality Control

AstraZeneca • New Haven (CT)

On-site
USD 138,000 - 208,000
401(k) retirement plan
Paid vacation and holidays
Health benefits
Director, Oncology Bioanalytical Strategy Lead
Director, Oncology Bioanalytical Strategy Lead

AstraZeneca GmbH • Cambridge (MA)

On-site
USD 175,000 - 260,000
Associate Director, Bioanalysis (Cell Therapy)
Associate Director, Bioanalysis (Cell Therapy)

AstraZeneca GmbH • Santa Monica (CA)

On-site
USD 142,000 - 214,000
Incentives and bonuses
Equity-based awards
Retirement plan
+4